Impact of scFv structure in chimeric antigen receptor on receptor expression efficiency and antigen recognition properties-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of scFv structure in chimeric antigen receptor on receptor expression efficiency and antigen recognition properties

Published:2020-06 Issue:2 Volume:527 Page:350-357
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Fujiwara Kento,Masutani Mizuki,Tachibana Masashi^ORCID,Okada Naoki

Funder

JSPS KAKENHI

SENSHIN Medical Research Foundation Grant-in-Aid

Takeda Research Support 2019

Takeda Science Foundation Grant-in-Aid

AMED

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference21 articles.

1. Limitations in the design of chimeric antigen receptors for cancer therapy;Stoiber;Cells,2019

2. Chimeric antigen receptor therapy;June;N. Engl. J. Med.,2018

3. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors;Eshhar;Proc. Natl. Acad. Sci. U.S.A.,1993

4. Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward;Li;J. Hematol. Oncol.,2018

5. IFN-γ and TNF-α aggravate endothelial damage caused by CD123-targeted CAR T cell;Sun;OncoTargets Ther.,2019

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimization of anti-TIM3 chimeric antigen receptor with CD8α spacer and TNFR-based costimulation for enhanced efficacy in AML therapy;Biomedicine & Pharmacotherapy;2024-10

2. Advances in bioengineered CAR T/NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology‐based strategies for enhanced CAR T/NK cell therapy;Bioengineering & Translational Medicine;2024-08-31

3. Conversion of anti-tissue factor antibody sequences to chimeric antigen receptor and bi-specific T-cell engager format;Cancer Immunology, Immunotherapy;2024-08-06

4. B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors;Cancer Research Communications;2024-06-04

5. Novel OX40 and 4-1BB derived spacers enhance CD30 CAR activity and safety in CD30 positive lymphoma models;Molecular Therapy;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3